NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-131281 |   Medical Devices

Historical data: 2017 - 2023

Forecast period: 2025 - 2031

Quantitative units: Revenue in USD million and CAGR from 2025 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Nanoparticles In Biotechnology And Pharmaceuticals Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET

7.1 GLOBAL NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA NANOPARTICLES IN BIOTECHNOLOGY AND PHARMACEUTICALS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 Roche

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 GE Healthcare

16.3 Merck

16.4 Novartis

16.5 AMAG Pharmaceuticals

16.6 Amgen

16.7 Bausch & Lomb

16.8 Biogen

16.9 Celgene

16.10 Gilead

16.11 Ipsen

16.12 Leadiant Biosciences

16.13 nanoComposix

16.14 Pacira Pharmaceuticals

16.15 Pfizer

16.16 Shire

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Market by Type :

Fullerenes
Liquid Crystals
Liposomes
Nanoshells
Quantum dots
Superparamagnetic nanoparticles

Market by Application :

Biotechnology
Pharmaceutical

Companies

Roche
GE Healthcare
Merck
Novartis
AMAG Pharmaceuticals
Amgen
Bausch & Lomb
Biogen
Celgene
Gilead
Ipsen
Leadiant Biosciences
nanoComposix
Pacira Pharmaceuticals
Pfizer
Shire

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.